NDC 70518-3328

Potassium-cit

Potassium-cit

Potassium-cit is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Potassium Citrate.

Product ID70518-3328_d5653ac3-fbea-5a86-e053-2a95a90a5a99
NDC70518-3328
Product TypeHuman Prescription Drug
Proprietary NamePotassium-cit
Generic NamePotassium-cit
Dosage FormTablet, Extended Release
Route of AdministrationORAL
Marketing Start Date2022-01-11
Marketing CategoryANDA /
Application NumberANDA214426
Labeler NameREMEDYREPACK INC.
Substance NamePOTASSIUM CITRATE
Active Ingredient Strength10 meq/1
Pharm ClassesAcidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 70518-3328-0

100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-3328-0)
Marketing Start Date2022-01-11
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Potassium-cit" or generic name "Potassium-cit"

NDCBrand NameGeneric Name
70518-3328Potassium-citpotassium-cit
71930-048Potassium-citPotassium-cit
71930-049Potassium-citpotassium-cit
71930-050Potassium-citPotassium-cit

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.